In immunocompetent mice bearing CT26 colorectal cancer cells, both oxaliplatin and cisplatin-induced immune response, but not when CRT was inhibited or depleted or when the toll-like receptor 4 (TLR4) was knocked out [117]. This evidence concerns the gene TLR4 and colorectal cancer.